In summary, we provide a new approach that ATM inhibitors combined with TOP2 poison would synergistically suppresses lung cancer cell survival as well as reduce DNA damage responses, thus may lowering the possibility of cardiotoxicity and secondary malignancy linked to therapy. This evidence concerns the gene TOP2A and lung carcinoma.